Buchanan Life Sciences Executive Exchange Series – Session 3 Webinar Replay
Danforth’s Daniel Geffken joined panelists from Buchanan, Ingersoll and Rooney and JP Morgan to discuss the all-important subject of capital raising for life science companies. Topics included:
- The current financing climate; compression between rounds, the rise of the mezzanine round, the accelerated timeline to IPO
- The changed perception of SPACs – from “back door” to mainstream opportunity
- How the SPAC process differs from that of a traditional IPO; pros and cons
- Increased pressure on management teams to get IPO ready; how to prepare